Alex D. Nka

Yaounde, CE, Cameroon

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.

Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.

Journal: Infectious agents and cancer

Published: March 16, 2026

Brief communication: virological response and drug resistance patterns among men who have sex with men in Yaoundé-Cameroon.

Brief communication: virological response and drug resistance patterns among men who have sex with men in Yaoundé-Cameroon.

Journal: AIDS research and therapy

Published: February 18, 2026

Verification of False Reactivity in HIV Rapid Diagnostic Tests and Its Translation Into the Three Tests Algorithm in Cameroon.

Verification of False Reactivity in HIV Rapid Diagnostic Tests and Its Translation Into the Three Tests Algorithm in Cameroon.

Journal: Journal of clinical laboratory analysis

Published: February 02, 2026

Low Rates of Virologic Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.

Low Rates of Virologic Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.

Journal: The Pediatric infectious disease journal

Published: January 07, 2026

Efficacy of dolutegravir-based therapy in achieving virological suppression in PLHIV in low- and middle-income countries: real-world evidence from a large clinical cohort in Cameroon.

Efficacy of dolutegravir-based therapy in achieving virological suppression in PLHIV in low- and middle-income countries: real-world evidence from a large clinical cohort in Cameroon.

Journal: BMC infectious diseases

Published: December 05, 2025

Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries.

Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries.

Journal: PLOS global public health

Published: November 25, 2025

Hepatitis B immune escape and drug resistance mutations among blood donors in Gabon during the year 2022.

Hepatitis B immune escape and drug resistance mutations among blood donors in Gabon during the year 2022.

Journal: Scientific reports

Published: October 30, 2025

Three-Year Outcomes After Genotyping-Guided Treatment Switch in HIV Patients with Virologic Failure in Cameroon: Implications for Epidemic Control in Low- and Middle-Income Countries.

Three-Year Outcomes After Genotyping-Guided Treatment Switch in HIV Patients with Virologic Failure in Cameroon: Implications for Epidemic Control in Low- and Middle-Income Countries.

Journal: Journal of global antimicrobial resistance

Published: October 14, 2025

Advancing implementation science and policy on HIV/AIDS: outcomes from the fourth edition of the Cameroon HIV operational research forum (CAM-HERO) 2024.

Advancing implementation science and policy on HIV/AIDS: outcomes from the fourth edition of the Cameroon HIV operational research forum (CAM-HERO) 2024.

Journal: The Pan African medical journal

Published: October 10, 2025

MicroRNAs profiling in malaria and arbovirus coinfection: A systematic review protocol.

MicroRNAs profiling in malaria and arbovirus coinfection: A systematic review protocol.

Journal: PloS one

Published: September 15, 2025

Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries.

Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries.

Journal: Diagnostic microbiology and infectious disease

Published: September 04, 2025

Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon.

Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon.

Journal: AIDS research and therapy

Published: July 10, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026